Intuitive Surgical Wins World-First CE Mark for da Vinci SP Transvaginal Surgery

THINK Surgical, Inc. announced that Rick McDowell has joined the orthopedic surgical robot maker as Vice President, Sales. McDowell will report to Executive Vice President Chris Marrus and will lead the company's national sales organization, driving market strategy and growth as THINK Surgical scales its commercial operations. He brings more than 20 years of medical device commercialization, clinical strategy and capital sales experience, most recently serving as Chief Commercial Officer at Gigly, Inc. Before that he led capital sales for Procept BioRobotics across the North Central United States and spent over a decade at Stryker Robotics/Orthopaedics, most recently as Area Sales Director for the Southeast region. Earlier in his career at MAKO Surgical he served as Director, Clinical Sales, leading an 8-district, 90-member, $85 million national clinical sales organization, and over his career he has generated more than half a billion dollars in lifetime capital and disposable sales.

DePuy Synthes is showcasing its latest trauma innovations at the 2026 Orthopaedic Trauma Association Annual Meeting in Nashville, including four new VOLT plating systems, the MAXFRAME AUTOSTRUT with Bluetooth Multi-Axial Correction System, VELYS Trauma AI Assisted Surgery, and an expanded procedural solutions offering. The four new plating systems expand the company's flagship VOLT fracture fixation platform across the ankle, knee, and shoulder, extending its anatomic plating portfolio into some of the most common and clinically demanding fracture procedures. The MAXFRAME AUTOSTRUT with Bluetooth Multi-Axial Correction System is now commercially available in the U.S. and is described as the first and only system to combine fully automated device adjustments with real-time remote monitoring and treatment management for complex limb reconstruction. VELYS Trauma AI-Assisted Surgery, which delivers intraoperative surgical guidance and fracture reduction assistance with precise 3D guidance without trackers or reference bodies, is launching in the U.S. in 2027. The company is also expanding its trauma commercial portfolio to include a comprehensive soft tissue portfolio featuring DYNACORD, GRYPHON, SUPERHAWK, and HEALIX Anchor technologies, and will offer interactive demos of its SOURCEVIEW Analytics Platform. Paolo Di Vincenzo, Global President of Trauma at DePuy Synthes, said an estimated 178 million new fractures occur globally each year and that the company is expanding into connected care across the entire skeleton.